Ketorolac Tromethamine (Acuvail)

Trade Name : ACUVAIL

Allergan, Inc.

SOLUTION/ DROPS

Strength 4.5 mg/mL

KETOROLAC TROMETHAMINE Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Cyclooxygenase Inhibitor [EPC]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Ketorolac Tromethamine (Acuvail) which is also known as ACUVAIL and Manufactured by Allergan, Inc.. It is available in strength of 4.5 mg/mL per ml. Read more

Ketorolac Tromethamine (Acuvail) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • ACUVAIL
  • u00ae
  • ACUVAILu00a0ophthalmic solution is a nonsteroidal, anti-inflammatory indicated for the treatment of pain and inflammation following cataract surgery. ()
  • One drop of ACUVAILu00a0should be applied by the patient to the affected eye twice daily beginning 1 day prior to cataract surgery, and continued through the first 2 weeks of the postoperative period.u00a0()
  • 4.5 mg/mL ketorolac tromethamineu00a0solution (0.45%) in a single-use vial.
  • ACUVAILu00a0ophthalmic solution containing 4.5 mg/mL ketorolac tromethamine in a single-use vial. ()
  • ACUVAILu00a0solution is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation.
  • Hypersensitivity to any component of this product. ()
  • No data
  • Delayed healing ()n
  • Cross-sensitivity or hypersensitivity () n
  • Increased bleeding time due to interference with thrombocyte aggregation ()n
  • Corneal effects including keratitis ()
  • Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to the rates in the clinical studies of another drug and may not reflect the rates observed in practice.
  • Most common adverse reactions occurring in 1-6% of patients wereu00a0increased intraocular pressure, conjunctival hemorrhage, and vision blurred. ()
  • No data
  • ACUVAILu00a0(ketorolac tromethamine ophthalmic solution) 0.45%u00a0is a member of the pyrrolo-pyrrole group of nonsteroidal anti-inflammatory drugs (NSAIDs) for ophthalmic use. Its chemical name is (u00b1)-5-Benzoyl-2,3-dihydro-1-pyrrolizine-1-carboxylic acid, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), and its molecular weight is 376.40. Its molecular formula is CHNO. Its chemical structure is:
  • ACUVAILn- u00a0
  • Each mL of ACUVAILu00a0ophthalmic solution contains:ketorolac tromethamine 0.45%.u00a0n carboxymethylcellulose sodium; sodium chloride; sodium citrate dihydrate; and purified water with sodium hydroxide and/or hydrochloric acid to adjust pH.u00a0
  • No data
  • Ketorolac tromethamine was not carcinogenic in either rats given up to 5 mg/kg/day orally for 24 monthsu00a0or in mice given 2 mg/kg/day orally for 18 months. These doses are approximately 900 times and 300 times higher respectively than the typical human topical ophthalmic daily dose given as twice daily to an affected eye on a mg/kg basis.
  • Ketorolac tromethamine was not mutagenic in the Amesassay or in forward mutation assays. Similarly, it did not result in anu00a0u00a0increase in unscheduled DNA synthesis or anu00a0u00a0increase in chromosome breakage in mice. However, ketorolac tromethamine did result in an increased incidence in chromosomal aberrations in Chinese hamster ovary cells.
  • Ketorolac tromethamine did not impair fertility when administered orally to male and female rats at doses up to 9 mg/kg/day and 16 mg/kg/day, respectively. These doses are respectively 1500 and 2700 times higher than the typical human topical ophthalmic daily dose.
  • Two multicenter, randomized, double-masked, parallel group comparison studies including approximately 500 patients were conducted to evaluate the effects of ACUVAILu00a0on anterior chamber cell and flare, and ocular pain relief following cataract extraction with posterior chamber intraocular lens (IOL) implantation. Results of these studies indicated that patients receiving ACUVAILu00a0had a significantly higher incidence of clearing of anterior chamber inflammation 53% (167/318) versusu00a0patients receiving vehicle 26% (41/155)u00a0at day 14.
  • ACUVAILu00a0was also significantly superior to vehicle in resolving ocular pain. On Day 1 post cataract surgery, 72% (233/322) of patients in the ACUVAILu00a0group were pain free compared to 40% (62/156) of patients in the vehicle group.
  • Results from clinical studies indicate that ketorolac tromethamine has no significant effect upon intraocular pressure; however, changes in intraocular pressure may occur following cataract surgery.
  • ACUVAILu00a0(ketorolac tromethamine ophthalmic solution) 0.45% is available as a sterile solution supplied in clear, LDPE, single-use vials packaged in 3 foil pouches, 10 vials per pouch:
  • 30 Single-Use Vials 0.4 mL each: NDC 0023-3507-31
  • Storagen- :
  • No data
  • NDC 0023-3507-31ACUVAIL(ketorolac tromethamineophthalmic solution)0.45%Preservative-FreeFOR SINGLE-USE ONLYRx Onlysterile
  • NDC 0023-3507-30ACUVAIL(ketorolac tromethamineophthalmic solution)0.45%Preservative-FreeFOR SINGLE-USE ONLYRx Onlysterile
  • NDC 0023-3507-31ACUVAIL(ketorolac tromethamineophthalmic solution)0.45%Preservative-FreeFOR SINGLE-USE ONLYRx Onlysterile

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.